United States· US:82715-106_6867bdd4-71da-4143-adb4-0f1d84bd1c1d
GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15
A octinoxate product containing octinoxate, registered in United States by ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Octinoxate is registered in 2 of 19 countries.
Countries holding a registration under ATC D02BA02 (octinoxate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Octinoxate · ATC D02BA02
2 / 19 countries
- Canada
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE
- Manufacturer
- ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI
- Country
- United States (US)
- ATC code
- D02BA02
- ATC class
- Octinoxate
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 50
- ndc1182715-106-09
- ndc11827151060130 mL in 1 TUBE (82715-106-01)
- ndc11827151060230 mL in 1 TUBE (82715-106-02)
- ndc11827151060330 mL in 1 TUBE (82715-106-03)
- ndc11827151060430 mL in 1 TUBE (82715-106-04)
- ndc11827151060530 mL in 1 TUBE (82715-106-05)
- ndc11827151060630 mL in 1 TUBE (82715-106-06)
- ndc11827151060730 mL in 1 TUBE (82715-106-07)
- ndc11827151060830 mL in 1 TUBE (82715-106-08)
- ndc11827151060930 mL in 1 TUBE (82715-106-09)
- ndc11827151061030 mL in 1 TUBE (82715-106-10)
- ndc11827151061130 mL in 1 TUBE (82715-106-11)
- ndc11827151061230 mL in 1 TUBE (82715-106-12)
- ndc11827151061330 mL in 1 TUBE (82715-106-13)
- ndc11827151061430 mL in 1 TUBE (82715-106-14)
- ndc11827151061530 mL in 1 TUBE (82715-106-15)
- ndc11827151061630 mL in 1 TUBE (82715-106-16)
- ndc11827151061730 mL in 1 TUBE (82715-106-17)
- ndc11827151061830 mL in 1 TUBE (82715-106-18)
- ndc11827151061930 mL in 1 TUBE (82715-106-19)
- ndc11827151062030 mL in 1 TUBE (82715-106-20)
- ndc11827151062130 mL in 1 TUBE (82715-106-21)
- ndc11827151062230 mL in 1 TUBE (82715-106-22)
- ndc11827151062330 mL in 1 TUBE (82715-106-23)
- ndc11827151062430 mL in 1 TUBE (82715-106-24)
- ndc11827151062530 mL in 1 TUBE (82715-106-25)
- ndc1182715-106-01
- ndc1182715-106-02
- ndc1182715-106-03
- ndc1182715-106-04
- ndc1182715-106-05
- ndc1182715-106-06
- ndc1182715-106-07
- ndc1182715-106-08
- ndc1182715-106-10
- ndc1182715-106-11
- ndc1182715-106-12
- ndc1182715-106-13
- ndc1182715-106-14
- ndc1182715-106-15
- ndc1182715-106-16
- ndc1182715-106-17
- ndc1182715-106-18
- ndc1182715-106-19
- ndc1182715-106-20
- ndc1182715-106-21
- ndc1182715-106-22
- ndc1182715-106-23
- ndc1182715-106-24
- ndc1182715-106-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octinoxate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd779de9-a4f0-4193-840e-4028b187429b GET /v1/drugs/bd779de9-a4f0-4193-840e-4028b187429b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "OCTINOXATE",
"productndc": "82715-106",
"dosage_form": "LOTION",
"dea_schedule": null,
"strength_unit": "g/100mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.